Tresiba
NDC 0169-2662, insulin degludec, injection, solution, from Novo Nordisk.
- Product NDC
- 0169-2662
- Status
- Listed
- Labeler
- Novo Nordisk
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA203314
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2662 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN DEGLUDEC100 U/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-2662-11 | 00169266211 | 1 VIAL, GLASS in 1 CARTON (0169-2662-11) / 10 mL in 1 VIAL, GLASS |
| 0169-2662-90 | 00169266290 | 1 VIAL, GLASS in 1 CARTON (0169-2662-90) / 10 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/456c5e87-3dfd-46fa-8ac0-c6128d4c97c6NADAC price for package 00169266211
GET /v1/drugs/nadac/00169266211
Use it
Look up 0169-2662 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2662 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-2662. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.